[ad_1]
The agency stated that the temporary hiatus should initially be extended until December 1 and explained that it had received evidence of an increased risk of side effects such as myocarditis and pericarditis.
“The Public Health Agency has decided to temporarily suspend the use of the Moderna vaccine, Spikevax, for all people after 1991 for safety reasons. The agency said in a statement adding that this age group should be vaccinated with Pfizer-BioNTech. instead.
According to the agency, the risk is primarily related to the second dose of the Moderna vaccine, and it was seen most often in boys and young men a few weeks after the second dose.
Symptoms usually go away on their own, but still need to be evaluated by a doctor, the agency added.
“People who have recently received the first or second dose of Moderna need not worry as the risk is very low, but it is well known what the symptoms could be,” the country’s chief epidemiologist Anders Tegnell said in a statement. .
In Sweden, 81,000 people have received the first dose of the Moderna vaccine so far. people in this age group, but will not be offered a second dose, the agency said, adding that “there is currently a debate about the best solution for this group.”
The European Medicines Agency (EMA) has given the green light to vaccinate adolescents with the Moderna vaccine in July.
